Find the latest oncology news for your sub-specialty area
Overcoming the limits of immunotherapies
CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this…
Find the latest oncology news for your sub-specialty area
CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this…
Cervical cancer is a highly prevalent cancer, with approximately 500,000 new cases diagnosed each year.…
A new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable…
New recommendations for screening and treatment are based on the results of a major national…
The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumours,…
Ductal carcinoma in situ (DCIS) is a type of preinvasive tumour that sometimes progresses to…
In patients with diffuse large B-cell non-Hodgkin lymphoma (DLBCL), the two hallmark post-chimeric antigen receptor…
Receptor protein tyrosine phosphatases are cell membrane-localised proteins. They are regulators of cell-cell contacts and…
A team of investigators from UCLA, USA, has identified distinct patient preference-based profiles among men…
Ian Musgrave, University of Adelaide A major Federal Court class action has been dismissed this…